Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector February 2026 highlights: Gilead buys Arcellx for US$ 7.8 bn; FDA okays Vanda’s psychotic pill

Stock Recap
#PipelineProspector

Wellbutrin;Zyban;Voxra;Budeprion;Aplenzin;Bupropion

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

84 API Suppliers, 38 USDMF, 14 EU WC, 12 KDMF, 35 NDC API, 40 Listed Suppliers

DEVELOPMENTS

50 Drugs in Development

50 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers, 138 FDA Orange Book, 157 Europe, 12 Canada, 2 Australia, 19 South Africa, 21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG, TABLET, EXTENDED RELEASE;ORAL - 100MG, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 200MG, TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - 150MG, TABLET, EXTENDED RELEASE;ORAL - 300MG, TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem, 7 Evonik, 2 Rochem International Inc, 20 SPI Pharma, 3 Boai NKY Pharmaceuticals Ltd, 6 Gangwal Healthcare, 9 Nanjing Well Pharmaceutical, 1 Shanghai Minbiotech, 1 Pfanstiehl, 1 Capital Farma, 6 Kirsch Pharma, 1 Panvo Organics, 3 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 6 Actylis, 1 Aeon Procare, 2 Alcedo Pharmachem, 6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 3 Ashland, 35 BASF, 1 CD Formulation, 2 Clariant, 16 Corel Pharma Chem, 5 DFE Pharma, 3 Doshion Polyscience, 1 Esteem Industries, 3 Finar, 12 Gangwal Chemicals, 2 Gloria Interchem, 1 Huzhou Sunflower Pharmaceutical, 13 Ideal Cures, 3 Ingredion Pharma Solutions, 26 Kerry, 2 Keval Exports, 5 Kima Chemical, 6 Lonza Capsugel, 21 Microlex e.U, 1 Nanjing Bold Chemical, 1 Neelkanth MineChem, 3 Nitika Pharmaceutical Specialities, 2 Nomisma Healthcare, 4 Novo Excipients, 3 Pharmatrans-Sanaq, 7 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 19 Roquette, 14 Seppic, 5 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 9 Sigachi Industries, 2 Silverline Chemicals, 4 The Dow Chemical Company, 2 Valens Pharmachem, 2 Vasa Pharmachem, 2 Vertellus

EXCIPIENTS BY APPLICATIONS

78 Fillers, Diluents & Binders, 74 Coating Systems & Additives, 45 Controlled & Modified Release, 43 Direct Compression, 39 Solubilizers, 35 Granulation, 34 Thickeners and Stabilizers, 28 Lubricants & Glidants, 28 Film Formers & Plasticizers, 28 Taste Masking, 24 Parenteral, 23 Topical, 19 Chewable & Orodispersible Aids, 17 Disintegrants & Superdisintegrants, 14 Co-Processed Excipients, 11 Emulsifying Agents, 9 API Stability Enhancers, 6 Surfactant & Foaming Agents, 6 Rheology Modifiers, 5 Empty Capsules, 4 Vegetarian Capsules, 2 Coloring Agents

DIGITAL CONTENT

97 News #PharmaBuzz

97 News #PharmaBuzz

GLOBAL SALES INFORMATION

58 US Medicaid Prescriptions, 46 Regulatory FDF Prices, 10 Annual Reports

MARKET PLACE

12 APIs, 2 FDF Dossiers

PATENTS & EXCLUSIVITIES

19 US Patents, 26 Health Canada Patents

REF. STANDARDS & IMPURITIES

4 USP, 25 Others

ANALYTICAL

2 BioAnalytical Methods

2 BioAnalytical Methods

Xls download

Filters

List of Suppliers

Reset Filter

Price Info

Product Main Page

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	Registration No.	Compound	Registration Date	Manufacturer	Manufacturer's Country	Manufacturer's Address
27/02/2026	Alembic Pharmaceuticals Limited	India	HiPharm Co., Ltd.	20200402-209-J-326(2)	Bupropion hydrochloride	2026-02-11	Alembic Pharmaceuticals Limited (API Division-II)	India	Survey No. 144P1, 144P2, 144P3, 145P, 137, 138, 139, 140, Panelav, Tal-Halol, Dist.-Panchmahal, Gujarat state, India
27/02/2026	Alembic Pharmaceuticals Limited	India	Hwail Pharmaceutical Co., Ltd.	20200402-209-J-326(1)	Bupropion hydrochloride	2020-05-19	Alembic Pharmaceuticals Limited (API Division-II)	India	Survey No. 144P1, 144P2, 144P3, 145P, 137, 138, 139, 140, Panelav, Tal-Halol, Dist.-Panchmahal, Gujarat state, India

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Wellbutrin;Zyban;Voxra;Budeprion;Aplenzin;Bupropion

Wellbutrin;Zyban;Voxra;Budeprion;Aplenzin;Bupropion

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

84 API Suppliers

38 USDMF

14 EU WC

12 KDMF

35 NDC API

40 Listed Suppliers

DEVELOPMENTS

50 Drugs in Development

INTERMEDIATES

9 Intermediate Suppliers

FINISHED DOSAGE FORMULATIONS

349 FDF Dossiers

138 FDA Orange Book

157 Europe

12 Canada

2 Australia

19 South Africa

21 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET;ORAL - 100MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 50MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET;ORAL - 75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG

TABLET, EXTENDED RELEASE;ORAL - 100MG

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 200MG

TABLET, EXTENDED RELEASE;ORAL - 150MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - 150MG

TABLET, EXTENDED RELEASE;ORAL - 300MG

TABLET, EXTENDED RELEASE;ORAL - 450MG

RELATED EXCIPIENT COMPANIES

1 Minakem

7 Evonik

2 Rochem International Inc

20 SPI Pharma

3 Boai NKY Pharmaceuticals Ltd

6 Gangwal Healthcare

9 Nanjing Well Pharmaceutical

1 Shanghai Minbiotech

1 Pfanstiehl

1 Capital Farma

6 Kirsch Pharma

1 Panvo Organics

3 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

6 Actylis

1 Aeon Procare

2 Alcedo Pharmachem

6 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

3 Ashland

35 BASF

1 CD Formulation

2 Clariant

16 Corel Pharma Chem

5 DFE Pharma

3 Doshion Polyscience

1 Esteem Industries

3 Finar

12 Gangwal Chemicals

2 Gloria Interchem

1 Huzhou Sunflower Pharmaceutical

13 Ideal Cures

3 Ingredion Pharma Solutions

26 Kerry

2 Keval Exports

5 Kima Chemical

6 Lonza Capsugel

21 Microlex e.U

1 Nanjing Bold Chemical

1 Neelkanth MineChem

3 Nitika Pharmaceutical Specialities

2 Nomisma Healthcare

4 Novo Excipients

3 Pharmatrans-Sanaq

TABLET;ORAL - 100MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 50MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET;ORAL - 75MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

TABLET, EXTENDED RELEASE;ORAL - 150MG Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons